Portal de Periódicos da CAPES

Imiquimod 5% cream in occlusion, for the treatment of lentigo maligna: A new scheme of short cycles and the need for clinical trials

2018; Wiley; Volume: 32; Issue: 1 Linguagem: Inglês

10.1111/dth.12757

1529-8019

Stefano Astorino, Paolo Astorre, Paola Pasquini, Donato Di Nunno, F Pellegrini, Giovanni Paolino,

Cutaneous lymphoproliferative disorders research

Dermatologic TherapyVolume 32, Issue 1 e12757 Therapeutic Hotline: Letter Imiquimod 5% cream in occlusion, for the treatment of lentigo maligna: A new scheme of short cycles and the need for clinical trials Stefano Astorino, Stefano Astorino Dermatology and Venereology, Celio Military Hospital, Rome, Italy Department of Internal Medicine, Celio Military Hospital, Rome, ItalySearch for more papers by this authorPaolo Astorre, Paolo Astorre Department of Oncology, Celio Military Hospital, Rome, ItalySearch for more papers by this authorPaola Pasquini, Paola Pasquini Service of Surgical Pathology, Celio Military Hospital, Rome, ItalySearch for more papers by this authorDonato Di Nunno, Donato Di Nunno Dermatology and Venereology, Celio Military Hospital, Rome, Italy Department of Internal Medicine, Celio Military Hospital, Rome, ItalySearch for more papers by this authorFederico Pellegrini, Federico Pellegrini Department of Oncology, Celio Military Hospital, Rome, ItalySearch for more papers by this authorGiovanni Paolino, Corresponding Author Giovanni Paolino paolgio@libero.it orcid.org/0000-0002-4146-8975 Unit of Dermatology, IRCCS University Vita-Salute San Raffaele, Milan, Italy Department of Dermatology, Dipartimento di Medicina Interna e Specialità Mediche, La Sapienza University of Rome, Rome, Italy Correspondence Giovanni Paolino, Department of Dermatology, Dipartimento di Medicina Interna e Specialità Mediche, La Sapienza University of Rome, Rome, Italy Email: paolgio@libero.itSearch for more papers by this author Stefano Astorino, Stefano Astorino Dermatology and Venereology, Celio Military Hospital, Rome, Italy Department of Internal Medicine, Celio Military Hospital, Rome, ItalySearch for more papers by this authorPaolo Astorre, Paolo Astorre Department of Oncology, Celio Military Hospital, Rome, ItalySearch for more papers by this authorPaola Pasquini, Paola Pasquini Service of Surgical Pathology, Celio Military Hospital, Rome, ItalySearch for more papers by this authorDonato Di Nunno, Donato Di Nunno Dermatology and Venereology, Celio Military Hospital, Rome, Italy Department of Internal Medicine, Celio Military Hospital, Rome, ItalySearch for more papers by this authorFederico Pellegrini, Federico Pellegrini Department of Oncology, Celio Military Hospital, Rome, ItalySearch for more papers by this authorGiovanni Paolino, Corresponding Author Giovanni Paolino paolgio@libero.it orcid.org/0000-0002-4146-8975 Unit of Dermatology, IRCCS University Vita-Salute San Raffaele, Milan, Italy Department of Dermatology, Dipartimento di Medicina Interna e Specialità Mediche, La Sapienza University of Rome, Rome, Italy Correspondence Giovanni Paolino, Department of Dermatology, Dipartimento di Medicina Interna e Specialità Mediche, La Sapienza University of Rome, Rome, Italy Email: paolgio@libero.itSearch for more papers by this author First published: 04 October 2018 https://doi.org/10.1111/dth.12757Citations: 4Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume32, Issue1January/February 2019e12757 RelatedInformation